A high incidence of viable Mycobacterium leprae in post-MDT recurrent lesions in tuberculoid leprosy patients.
Shetty
V P
VP
Foundation for Medical Research, 84A R.G. Thadani Marg, Worli Seaface, Mumbai 400 018. frchbom@bom2.vsnl.net.in
Wakade
A
A
Antia
N H
NH
D000293:Adolescent; D000328:Adult; D000368:Aged; D000818:Animals; D001681:Biological Assay; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007917:Leprostatic Agents / Q000008:administration & dosage*; D015439:Leprosy, Borderline / Q000188:drug therapy / Q000382:microbiology; D015441:Leprosy, Tuberculoid / Q000188:drug therapy / Q000382:microbiology* / Q000473:pathology; D008297:Male; D051379:Mice; D008875:Middle Aged; D009166:Mycobacterium leprae / Q000254:growth & development*; D012008:Recurrence; D012867:Skin / Q000382:microbiology* / Q000473:pathology
D007917:Leprostatic Agents